Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'M2-MUSCARINIC DRUGS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 13 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hoffmann, IS; Guevara, BH; Cubeddu, LX
      Potassium, M3 muscarinic receptors and dopamine release

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    2. Perry, KW; Nisenbaum, LK; George, CA; Shannon, HE; Felder, CC; Bymaster, FP
      The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex

      BIOLOGICAL PSYCHIATRY
    3. Bairam, A; Neji, H; Marchal, F
      Cholinergic dopamine release from the in vitro rabbit carotid body

      JOURNAL OF APPLIED PHYSIOLOGY
    4. Khan, S; Whelpton, R; Michael-Titus, AT
      Substance P modulation of striatal dopamine outflow is determined by M-1 and M-2 muscarinic receptors in male Wistar rats

      NEUROSCIENCE LETTERS
    5. Izurieta-Sanchez, P; Sarre, S; Ebinger, G; Michotte, Y
      Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum

      EUROPEAN JOURNAL OF PHARMACOLOGY
    6. IZURIETASANCHEZ P; SARRE S; EBINGER G; MICHOTTE Y
      EFFECT OF TRIHEXYPHENIDYL, A NONSELECTIVE ANTIMUSCARINIC DRUG, ON DECARBOXYLATION OF L-DOPA IN HEMI-PARKINSON RATS

      European journal of pharmacology
    7. WIDZOWSKI D; HELANDER HF; WU ESC
      SELECTIVE MUSCARINIC M-1 ANTAGONISTS - DRUG DESIGN AND DISCOVERY

      Drug discovery today
    8. SMOLDERS I; BOGAERT L; EBINGER G; MICHOTTE Y
      MUSCARINIC MODULATION OF STRIATAL DOPAMINE, GLUTAMATE, AND GABA RELEASE, AS MEASURED WITH IN-VIVO MICRODIALYSIS

      Journal of neurochemistry
    9. DOURMAP N; CLERO E; COSTENTIN J
      INVOLVEMENT OF CHOLINERGIC NEURONS IN THE RELEASE OF DOPAMINE ELICITED BY STIMULATION OF MU-OPIOID RECEPTORS IN STRIATUM

      Brain research
    10. IINO T; KATSURA M; KURIYAMA K
      EFFECT OF VINCONATE, AN INDOLONAPHTHYRIDINE DERIVATIVE, ON DOPAMINE AND SEROTONIN CONCENTRATIONS IN DIALYSATE FROM THE STRIATUM OF FREELY MOVING RATS - BRAIN MICRODIALYSIS STUDIES

      The Journal of pharmacology and experimental therapeutics
    11. WARPMAN U; ZHANG X; NORDBERG A
      EFFECT OF TACRINE ON IN-VIVO RELEASE OF DOPAMINE AND ITS METABOLITES IN THE STRIATUM OF FREELY MOVING RATS

      The Journal of pharmacology and experimental therapeutics
    12. SMOLDERS I; SARRE S; VANHAESENDONCK C; EBINGER G; MICHOTTE Y
      EXTRACELLULAR STRIATAL DOPAMINE AND GLUTAMATE AFTER DECORTICATION ANDKAINATE RECEPTOR STIMULATION, AS MEASURED BY MICRODIALYSIS

      Journal of neurochemistry
    13. GOBERT A; RIVET JM; AUDINOT V; CISTARELLI L; SPEDDING M; VIAN J; PEGLION JL; MILLAN MJ
      FUNCTIONAL CORRELATES OF DOPAMINE D-3, RECEPTOR ACTIVATION IN THE RATIN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .2. BOTH D-2 AND SILENT D-3 AUTORECEPTORS CONTROL SYNTHESIS AND RELEASEIN MESOLIMBIC, MESOCORTICAL AND NIGROSTRIATAL PATHWAYS())

      The Journal of pharmacology and experimental therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/02/20 alle ore 11:44:25